Carbromal
| Names | |
|---|---|
| IUPAC name
2-Bromo-N-carbamoyl-2-ethylbutanamide | |
| Identifiers | |
3D model (JSmol) |
|
| ChEMBL | |
| ChemSpider | |
| ECHA InfoCard | 100.000.952 |
| EC Number |
|
| KEGG | |
| MeSH | carbromal |
PubChem CID |
|
| UNII | |
CompTox Dashboard (EPA) |
|
| |
| |
| Properties | |
| C7H13BrN2O2 | |
| Molar mass | 237.097 g·mol−1 |
| Appearance | White crystals |
| Odor | Odorless |
| Density | 1.544 g/cm3 |
| Melting point | 119 °C (246 °F; 392 K) |
| Soluble | |
| Solubility | soluble in chloroform, ether, acetone, benzene |
| log P | 1.623 |
| Acidity (pKa) | 10.69 |
| Basicity (pKb) | 3.31 |
| Structure | |
| rhombic | |
| Pharmacology | |
| N05CM04 (WHO) | |
| Related compounds | |
Related ureas |
Bromisoval |
Related compounds |
|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references | |
Carbromal is a hypnotic/sedative originally synthesized in 1909 by Bayer and subsequently marketed as Adalin. The drug was later sold by Parke-Davis in combination with pentobarbital, under the name Carbrital. As of 2015, it was still used in Hungary in combination with aminophenazone under the name Demalgon.